|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.507
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.395
|
|
|
|
lytic vacuole organization
|
GO:0080171 |
21 |
0.242
|
|
|
|
lysosome organization
|
GO:0007040 |
21 |
0.216
|
|
|
|
vacuole organization
|
GO:0007033 |
38 |
0.177
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.176
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.159
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.136
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.134
|
|
|
|
positive regulation of necrotic cell death
|
GO:0010940 |
1 |
0.125
|
|
|
|
autophagic vacuole assembly
|
GO:0000045 |
13 |
0.116
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.115
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.113
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.108
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.098
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.097
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.096
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.094
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.094
|
|
|
|
renin angiotensin regulation of aldosterone production
|
GO:0002018 |
3 |
0.093
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.092
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.089
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.087
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.085
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.084
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.083
|
|
|
|
establishment of melanosome localization
|
GO:0032401 |
11 |
0.083
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.082
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.082
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.082
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.079
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.074
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.073
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.072
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.069
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.068
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.067
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.065
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.064
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.063
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.062
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.060
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.060
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.059
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.059
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.058
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.057
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.057
|
|
|
|
golgi to endosome transport
|
GO:0006895 |
3 |
0.054
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.053
|
Mouse |
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.053
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.053
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.052
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.050
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.050
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.049
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.049
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.049
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.049
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.048
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.046
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.045
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.045
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.045
|
|
|
|
central nervous system neuron axonogenesis
|
GO:0021955 |
28 |
0.044
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.044
|
|
|
|
macroautophagy
|
GO:0016236 |
21 |
0.044
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.042
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.042
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.041
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.041
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.041
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.041
|
|
|
|
sphingoid metabolic process
|
GO:0046519 |
5 |
0.040
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.039
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.039
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.039
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.039
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.039
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.038
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.038
|
|
|
|
cellular pigmentation
|
GO:0033059 |
20 |
0.038
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.037
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.037
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.037
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.036
|
|
|
|
negative regulation of vesicle fusion
|
GO:0031339 |
1 |
0.035
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.035
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.035
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.034
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.034
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.034
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.033
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.033
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.033
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.032
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.032
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.032
|
|
|
|
regulation of transposition
|
GO:0010528 |
2 |
0.032
|
|
|
|
glycosylceramide metabolic process
|
GO:0006677 |
4 |
0.031
|
|
|
|
heterochromatin assembly
|
GO:0031507 |
2 |
0.030
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.029
|
|
|
|
negative regulation of gene silencing
|
GO:0060969 |
2 |
0.029
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.028
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.028
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.028
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.028
|
|
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
1 |
0.028
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.028
|
|
|
|
regulation of arp2 3 complex mediated actin nucleation
|
GO:0034315 |
1 |
0.028
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.028
|
|
|
|
phospholipid transfer to membrane
|
GO:0006649 |
2 |
0.027
|
|
|
|
glycolipid metabolic process
|
GO:0006664 |
25 |
0.027
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.027
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.027
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.027
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.026
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.026
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.026
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.026
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.026
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.026
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.025
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.025
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.025
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.025
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.025
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.025
|
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.024
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.024
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.024
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.024
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.024
|
|
|
|
glycosphingolipid catabolic process
|
GO:0046479 |
5 |
0.024
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.023
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.023
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.023
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.023
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.023
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.023
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.023
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.023
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.023
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.023
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.023
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.022
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.022
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.022
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.022
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.022
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.022
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.022
|
|
|
|
cellular response to nerve growth factor stimulus
|
GO:1990090 |
3 |
0.022
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.021
|
|
|
|
hepatocyte growth factor receptor signaling pathway
|
GO:0048012 |
3 |
0.021
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.021
|
|
|
|
cell cycle switching
|
GO:0060184 |
1 |
0.021
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.021
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
36 |
0.021
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.021
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.021
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.021
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.021
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.020
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.020
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.020
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.020
|
|
|
|
regulation of vesicle fusion
|
GO:0031338 |
6 |
0.020
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.020
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.020
|
|
|
|
attachment of spindle microtubules to kinetochore
|
GO:0008608 |
4 |
0.020
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.020
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.020
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.020
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.020
|
|
|
|
protein localization to cell leading edge
|
GO:1902463 |
1 |
0.019
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.019
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.019
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.019
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.019
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.019
|
|
|
|
adherens junction maintenance
|
GO:0034334 |
1 |
0.019
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.019
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.019
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.019
|
|
|
|
pigment granule localization
|
GO:0051875 |
13 |
0.019
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
34 |
0.019
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.019
|
|
|
|
necrotic cell death
|
GO:0070265 |
30 |
0.019
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.019
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.019
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.019
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.019
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.018
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.018
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.018
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.018
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.018
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.018
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.018
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.018
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.018
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.018
|
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
38 |
0.018
|
|
|
|
hair cell differentiation
|
GO:0035315 |
40 |
0.018
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.018
|
|
|
|
arp2 3 complex mediated actin nucleation
|
GO:0034314 |
3 |
0.018
|
|
|
|
oocyte maturation
|
GO:0001556 |
18 |
0.018
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.018
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.018
|
|
|
|
cerebellar cortex formation
|
GO:0021697 |
22 |
0.018
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.018
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.017
|
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.017
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.017
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.017
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.017
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.017
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.017
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.017
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.017
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.017
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.017
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.017
|
|
|
|
hydrogen ion transmembrane transport
|
GO:1902600 |
25 |
0.017
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.017
|
|
|
|
regulation of endoplasmic reticulum stress induced intrinsic apoptotic signaling pathway
|
GO:1902235 |
11 |
0.017
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.017
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.017
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.017
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.017
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.017
|
|
|
|
uropod organization
|
GO:0032796 |
2 |
0.016
|
|
|
|
synapsis
|
GO:0007129 |
34 |
0.016
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.016
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.016
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.016
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.016
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.016
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.016
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.016
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.016
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.016
|
|
|
|
regulation of response to drug
|
GO:2001023 |
2 |
0.016
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
27 |
0.016
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.016
|
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.016
|
|
|
|
cellular carbohydrate catabolic process
|
GO:0044275 |
15 |
0.016
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.016
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.016
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.016
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.016
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.015
|
|
|
|
modification by symbiont of host morphology or physiology
|
GO:0044003 |
4 |
0.015
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.015
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.015
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.015
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.015
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.015
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.015
|
|
|
|
calcium ion transport into cytosol
|
GO:0060402 |
48 |
0.015
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.015
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.015
|
|
|
|
negative regulation of transposition
|
GO:0010529 |
2 |
0.015
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.015
|
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.015
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.015
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.015
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.015
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.015
|
|
|
|
regulation of actin nucleation
|
GO:0051125 |
4 |
0.015
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.015
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.015
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.015
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.015
|
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
31 |
0.015
|
|
|
|
schwann cell differentiation
|
GO:0014037 |
26 |
0.015
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.015
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.014
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.014
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.014
|
|
|
|
heterochromatin organization
|
GO:0070828 |
4 |
0.014
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.014
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.014
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.014
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.014
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.014
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.014
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.014
|
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.014
|
|
|
|
positive regulation of lamellipodium organization
|
GO:1902745 |
3 |
0.014
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.014
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.014
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.014
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.014
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.014
|
|
|
|
ceramide catabolic process
|
GO:0046514 |
7 |
0.014
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.014
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.014
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.013
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.013
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.013
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.013
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.013
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.013
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.013
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.013
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.013
|
|
|
|
response to copper ion
|
GO:0046688 |
3 |
0.013
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.013
|
|
|
|
positive regulation of cell division
|
GO:0051781 |
31 |
0.013
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.013
|
|
|
|
vegf activated neuropilin signaling pathway involved in axon guidance
|
GO:1902378 |
1 |
0.013
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.013
|
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
2 |
0.013
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.013
|
|
|
|
membrane lipid catabolic process
|
GO:0046466 |
8 |
0.013
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.013
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.013
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.013
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.013
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.013
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.013
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.013
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.013
|
|
|
|
positive regulation of actin nucleation
|
GO:0051127 |
3 |
0.013
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.013
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.013
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.012
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.012
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.012
|
|
|
|
positive regulation of protein acetylation
|
GO:1901985 |
9 |
0.012
|
|
|
|
sphingosine metabolic process
|
GO:0006670 |
4 |
0.012
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.012
|
|
|
|
homeostasis of number of cells within a tissue
|
GO:0048873 |
25 |
0.012
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.012
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.012
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.012
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.012
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.012
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.012
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.012
|
|
|
|
embryonic retina morphogenesis in camera type eye
|
GO:0060059 |
7 |
0.012
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.012
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.012
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.012
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.012
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.012
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.012
|
|
|
|
myelination in peripheral nervous system
|
GO:0022011 |
19 |
0.012
|
|
|
|
positive regulation of macroautophagy
|
GO:0016239 |
3 |
0.012
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.012
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.012
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.012
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.012
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.012
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.012
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.012
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.012
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.012
|
|
|
|
cell cycle switching mitotic to meiotic cell cycle
|
GO:0051728 |
1 |
0.012
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.012
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.011
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.011
|
|
|
|
oligosaccharide metabolic process
|
GO:0009311 |
11 |
0.011
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.011
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.011
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.011
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.011
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.011
|
|
|
|
vesicle fusion
|
GO:0006906 |
16 |
0.011
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.011
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.011
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.011
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.011
|
|
|
|
proton transport
|
GO:0015992 |
35 |
0.011
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.011
|
|
|
|
regulation of angiotensin levels in blood
|
GO:0002002 |
4 |
0.011
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.011
|
|
|
|
negative regulation of stress fiber assembly
|
GO:0051497 |
4 |
0.011
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.011
|
|
|
|
female meiosis chromosome segregation
|
GO:0016321 |
1 |
0.011
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.011
|
|
|
|
oligosaccharide catabolic process
|
GO:0009313 |
2 |
0.011
|
|
|
|
response to interleukin 4
|
GO:0070670 |
23 |
0.011
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.011
|
|
|
|
positive regulation of meiotic cell cycle
|
GO:0051446 |
15 |
0.011
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.011
|
|
|
|
aminoglycan metabolic process
|
GO:0006022 |
34 |
0.011
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.011
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.011
|
|
|
|
organelle fusion
|
GO:0048284 |
28 |
0.011
|
|
|
|
cerebral cortex tangential migration using cell axon interactions
|
GO:0021824 |
3 |
0.011
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.011
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.011
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.010
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.010
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.010
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.010
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.010
|
|
|
|
sphingolipid catabolic process
|
GO:0030149 |
7 |
0.010
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.010
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.010
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.010
|
|
|
|
maintenance of protein location in cell
|
GO:0032507 |
20 |
0.010
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.010
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.010
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.010
|
|
|
|
glycolipid catabolic process
|
GO:0019377 |
5 |
0.010
|
|
|
|
cellular polysaccharide metabolic process
|
GO:0044264 |
38 |
0.010
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.010
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.010
|
|
|
|
cellular amino acid catabolic process
|
GO:0009063 |
25 |
0.010
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.010
|
|
|
|
negative regulation of binding
|
GO:0051100 |
39 |
0.010
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.010
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.010
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.010
|
|